U.S. Food and Drug Administration Archives - CDR

Patient safety key as NACDS and APhA oppose prescription drug importation

January 21, 2019 by Chain Drug Review American Pharmacists Association (APhA), National Association of Chain Drug Stores (NACDS, Steven Anderson, Thomas Menighan, U.S. Food and Drug Administration Leading Headlines, Pharmacy

ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) and the American Pharmacists Association (APhA) expressed concerns about the risks to patient health and the security of the prescription drug supply chain in opposing legislation that would allow for personal and commercial importation of prescription drugs outside of the Food and Drug Administration’s (FDA)

FDA approves first marijuana-based prescription drug

June 26, 2018 by Chain Drug Review Epidiolex, Lennox-Gastaut syndrome and Dravet syndrome, medical marijuana, or CBD, purified cannabidiol, U.S. Food and Drug Administration Leading Headlines, Pharmacy

WASHINGTON — The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood. The drug is made from purified cannabidiol (CBD), a compound found in the cannabis plant. The drug